Show simple item record

dc.contributor.authorFoulkes-Murzycki, Jennifer E.
dc.contributor.authorScott, Walter Robert Peter
dc.contributor.authorSchiffer, Celia A.
dc.date2022-08-11T08:09:33.000
dc.date.accessioned2022-08-23T16:35:09Z
dc.date.available2022-08-23T16:35:09Z
dc.date.issued2007-02-13
dc.date.submitted2009-03-16
dc.identifier.citation<p>Structure. 2007 Feb;15(2):225-33. <a href="http://dx.doi.org/10.1016/j.str.2007.01.006">Link to article on publisher's site</a></p>
dc.identifier.issn0969-2126 (Print)
dc.identifier.doi10.1016/j.str.2007.01.006
dc.identifier.pmid17292840
dc.identifier.urihttp://hdl.handle.net/20.500.14038/38492
dc.description.abstractHydrophobic residues outside the active site of HIV-1 protease frequently mutate in patients undergoing protease inhibitor therapy; however, the mechanism by which these mutations confer drug resistance is not understood. From analysis of molecular dynamics simulations, 19 core hydrophobic residues appear to facilitate the conformational changes that occur in HIV-1 protease. The hydrophobic core residues slide by each other, exchanging one hydrophobic van der Waal contact for another, with little energy penalty, while maintaining many structurally important hydrogen bonds. Such hydrophobic sliding may represent a general mechanism by which proteins undergo conformational changes. Mutation of these residues in HIV-1 protease would alter the packing of the hydrophobic core, affecting the conformational flexibility of the protease. Therefore these residues impact the dynamic balance between processing substrates and binding inhibitors, and thus contribute to drug resistance.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=17292840&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2044563/
dc.subjectAmino Acids
dc.subjectDrug Resistance, Viral
dc.subjectHIV Protease
dc.subjectHIV Protease Inhibitors
dc.subjectHydrogen Bonding
dc.subjectHydrophobicity
dc.subjectMutation
dc.subjectProtein Conformation
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleHydrophobic sliding: a possible mechanism for drug resistance in human immunodeficiency virus type 1 protease
dc.typeJournal Article
dc.source.journaltitleStructure (London, England : 1993)
dc.source.volume15
dc.source.issue2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/1365
dc.identifier.contextkey783049
html.description.abstract<p>Hydrophobic residues outside the active site of HIV-1 protease frequently mutate in patients undergoing protease inhibitor therapy; however, the mechanism by which these mutations confer drug resistance is not understood. From analysis of molecular dynamics simulations, 19 core hydrophobic residues appear to facilitate the conformational changes that occur in HIV-1 protease. The hydrophobic core residues slide by each other, exchanging one hydrophobic van der Waal contact for another, with little energy penalty, while maintaining many structurally important hydrogen bonds. Such hydrophobic sliding may represent a general mechanism by which proteins undergo conformational changes. Mutation of these residues in HIV-1 protease would alter the packing of the hydrophobic core, affecting the conformational flexibility of the protease. Therefore these residues impact the dynamic balance between processing substrates and binding inhibitors, and thus contribute to drug resistance.</p>
dc.identifier.submissionpathoapubs/1365
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.source.pages225-33


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record